Biography
Research Interests
- Pharmacokinetic modelling
- Technology-enhanced learning in healthcare
- Experiential learning
- Deprescribing in community pharmacy
Publications
Peer Reviewed Journals
Year | Publication | |
---|---|---|
(2018) | 'Application of a Physiologically-Based Pharmacokinetic Model for the Prediction of Bumetanide Plasma and Brain Concentrations in the Neonate' Donovan, Maria D.,Abduljalil, Khaled,Cryan, John F.,Boylan, Geraldine B.,Griffin, Brendan T. (2018) 'Application of a Physiologically-Based Pharmacokinetic Model for the Prediction of Bumetanide Plasma and Brain Concentrations in the Neonate'. Biopharmaceutics & Drug Disposition, [DOI] [Details] | |
(2016) | 'In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide' Donovan, MD;Schellekens, H;Boylan, GB;Cryan, JE;Griffin, BT (2016) 'In vitro bidirectional permeability studies identify pharmacokinetic limitations of NKCC1 inhibitor bumetanide'. European Journal of Pharmacology, 770 :117-125 [DOI] [Details] | |
(2016) | 'Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives' Donovan, Maria D.; Griffin, Brendan T.; Kharoshankaya, Liudmila; Cryan, John F.; Boylan, Geraldine B. (2016) 'Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives'. Drugs, 76 :647-661 [DOI] [CORA Link] [Details] | |
(2015) | 'The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat' Donovan, MD;O'Brien, FE;Boylan, GB;Cryan, JF;Griffin, BT (2015) 'The effect of organic anion transporter 3 inhibitor probenecid on bumetanide levels in the brain: an integrated in vivo microdialysis study in the rat'. Journal of Pharmacy and Pharmacology, 67 :501-510 [DOI] [Details] | |
(2014) | 'The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram' O'Brien, FE;O'Connor, RM;Clarke, G;Donovan, MD;Dinan, TG;Griffin, BT;Cryan, JF (2014) 'The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram'. Behavioural Brain Research, 261 :17-25 [DOI] [Details] |
Reviews
Year | Publication | |
---|---|---|
(2016) | Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics. Donovan, MD;Boylan, GB;Murray, DM;Cryan, JF;Griffin, BT (2016) Treating disorders of the neonatal central nervous system: pharmacokinetic and pharmacodynamic considerations with a focus on antiepileptics. HOBOKEN: Reviews [DOI] [Details] | |
(2016) | Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs. Griffin, BT;Guo, JF;Presas, E;Donovan, MD;Alonso, MJ;O'Driscoll, CM (2016) Pharmacokinetic, pharmacodynamic and biodistribution following oral administration of nanocarriers containing peptide and protein drugs. AMSTERDAM: Reviews [DOI] [Details] |
Professional Activities
Professional Associations
Association | Function | From / To | |
---|---|---|---|
Pharmaceutical Society of Ireland | MPSI | / | |
European Society of Clinical Pharmacy | Member | / |
Education
Year | Institution | Qualification | Subject | |
---|---|---|---|---|
2012 | RCSI | MPharm | Pharmacy | |
2016 | UCC | PhD | Pharmaceutics | |
2011 | UCC | BPharm | Pharmacy |
Teaching Activities
Teaching Interests
- Clinical Pharmacokinetics
- Therapeutic Drug Monitoring
- Case-based learning in Clinical Pharmacy
- Statistics and Research Methods
- Experiential Learning
Modules Taught
Term (ID)) | Title | Link | Subject | |
---|---|---|---|---|
2019 | Pharmacology, Therapeutics and Rational Use of Drugs | PF6010 | Pharmacology, Therapeutics and Rational Use of Drugs |